Schedule 13G ownership disclosure

LogicBio Therapeutics, Inc.

Security class unavailable · CUSIP: 54142F102

Event date: 2021-02-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-009367
Form type
SC 13G/A
Filer
LogicBio Therapeutics, Inc.
CIK
CIK 1664106
Filed
Feb 16, 2021
Reporting period
Feb 07, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub